You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (0) |
Back to Search
Reclassification of medicines from prescription to non-prescription availability without industry sponsorship: two case studies
- In: Administrative Pharmacy Posters
- At: Lisbon (Portugal) (2010)
- Type: Poster
- Poster code: APS-P-005
- By: GAULD, Natalie (University of Auckland, Auckland, New Zealand)
- Co-author(s): Emmerton, Lynne (University of Queensland, BRISBANE, Australia)
Kelly, Fiona (University of Auckland, AUCKLAND, New Zealand)
Bryant, Linda (University of Auckland, AUCKLAND, New Zealand)
Buetow, Stephen (University of Auckland, AUCKLAND, New Zealand) - Abstract:
Background: Traditionally, reclassification of medicines from prescription to non-prescription has been initiated by pharmaceutical companies. However, industry support was not forthcoming regarding reclassification of chloramphenicol and calcipotriol in New Zealand (NZ). Potential consumer benefits of easier access to such medicines may require
.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026